nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—SH2B3—type 1 diabetes mellitus	0.678	1	CbGaD
Pazopanib—FGFR3—epiphyseal plate—type 1 diabetes mellitus	0.0146	0.16	CbGeAlD
Pazopanib—Ischaemic stroke—Ramipril—type 1 diabetes mellitus	0.00929	0.172	CcSEcCtD
Pazopanib—BMPR1B—peripheral nervous system—type 1 diabetes mellitus	0.00408	0.0449	CbGeAlD
Pazopanib—PDGFRA—penis—type 1 diabetes mellitus	0.00398	0.0438	CbGeAlD
Pazopanib—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.00355	0.0656	CcSEcCtD
Pazopanib—MAP3K9—islet of Langerhans—type 1 diabetes mellitus	0.00263	0.029	CbGeAlD
Pazopanib—FGF1—nerve—type 1 diabetes mellitus	0.00223	0.0245	CbGeAlD
Pazopanib—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.00215	0.0398	CcSEcCtD
Pazopanib—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.00212	0.0392	CcSEcCtD
Pazopanib—SH2B3—islet of Langerhans—type 1 diabetes mellitus	0.00186	0.0205	CbGeAlD
Pazopanib—MAP3K9—pancreas—type 1 diabetes mellitus	0.00185	0.0204	CbGeAlD
Pazopanib—SH2B3—retina—type 1 diabetes mellitus	0.00159	0.0175	CbGeAlD
Pazopanib—STK16—islet of Langerhans—type 1 diabetes mellitus	0.00158	0.0174	CbGeAlD
Pazopanib—SH2B3—nephron tubule—type 1 diabetes mellitus	0.0015	0.0165	CbGeAlD
Pazopanib—PI4KB—islet of Langerhans—type 1 diabetes mellitus	0.00138	0.0152	CbGeAlD
Pazopanib—SH2B3—cardiovascular system—type 1 diabetes mellitus	0.00135	0.0148	CbGeAlD
Pazopanib—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.00133	0.0246	CcSEcCtD
Pazopanib—Ageusia—Ramipril—type 1 diabetes mellitus	0.00132	0.0244	CcSEcCtD
Pazopanib—ITK—lymphoid tissue—type 1 diabetes mellitus	0.00132	0.0145	CbGeAlD
Pazopanib—SH2B3—pancreas—type 1 diabetes mellitus	0.00131	0.0144	CbGeAlD
Pazopanib—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00129	0.0239	CcSEcCtD
Pazopanib—RIOK2—nephron tubule—type 1 diabetes mellitus	0.00125	0.0138	CbGeAlD
Pazopanib—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00122	0.0225	CcSEcCtD
Pazopanib—PIP4K2C—islet of Langerhans—type 1 diabetes mellitus	0.00121	0.0133	CbGeAlD
Pazopanib—Protein urine present—Ramipril—type 1 diabetes mellitus	0.0012	0.0222	CcSEcCtD
Pazopanib—SH2B3—lymphoid tissue—type 1 diabetes mellitus	0.00113	0.0124	CbGeAlD
Pazopanib—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00113	0.0208	CcSEcCtD
Pazopanib—PI4KB—nephron tubule—type 1 diabetes mellitus	0.00111	0.0122	CbGeAlD
Pazopanib—FGFR3—kidney—type 1 diabetes mellitus	0.0011	0.0121	CbGeAlD
Pazopanib—PIP4K2C—retina—type 1 diabetes mellitus	0.00103	0.0114	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—type 1 diabetes mellitus	0.00102	0.0112	CbGeAlD
Pazopanib—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00101	0.0187	CcSEcCtD
Pazopanib—PI4KB—kidney—type 1 diabetes mellitus	0.000975	0.0107	CbGeAlD
Pazopanib—PIP4K2C—nephron tubule—type 1 diabetes mellitus	0.000973	0.0107	CbGeAlD
Pazopanib—PI4KB—pancreas—type 1 diabetes mellitus	0.000969	0.0107	CbGeAlD
Pazopanib—STK16—lymphoid tissue—type 1 diabetes mellitus	0.000962	0.0106	CbGeAlD
Pazopanib—LYN—lymphoid tissue—type 1 diabetes mellitus	0.000952	0.0105	CbGeAlD
Pazopanib—FLT1—islet of Langerhans—type 1 diabetes mellitus	0.000945	0.0104	CbGeAlD
Pazopanib—EPHB6—islet of Langerhans—type 1 diabetes mellitus	0.000934	0.0103	CbGeAlD
Pazopanib—FGF1—retina—type 1 diabetes mellitus	0.000923	0.0102	CbGeAlD
Pazopanib—MAP3K2—nephron tubule—type 1 diabetes mellitus	0.000923	0.0101	CbGeAlD
Pazopanib—TAOK3—islet of Langerhans—type 1 diabetes mellitus	0.000891	0.0098	CbGeAlD
Pazopanib—FLT4—cardiovascular system—type 1 diabetes mellitus	0.000879	0.00967	CbGeAlD
Pazopanib—FGF1—nephron tubule—type 1 diabetes mellitus	0.000869	0.00956	CbGeAlD
Pazopanib—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.000865	0.016	CcSEcCtD
Pazopanib—PIP4K2C—pancreas—type 1 diabetes mellitus	0.00085	0.00934	CbGeAlD
Pazopanib—LIMK2—lymphoid tissue—type 1 diabetes mellitus	0.000822	0.00904	CbGeAlD
Pazopanib—FLT1—retina—type 1 diabetes mellitus	0.000808	0.00889	CbGeAlD
Pazopanib—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.000797	0.0147	CcSEcCtD
Pazopanib—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000794	0.0147	CcSEcCtD
Pazopanib—FGF1—cardiovascular system—type 1 diabetes mellitus	0.000781	0.00859	CbGeAlD
Pazopanib—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000781	0.0144	CcSEcCtD
Pazopanib—FGF1—kidney—type 1 diabetes mellitus	0.000764	0.0084	CbGeAlD
Pazopanib—TAOK3—retina—type 1 diabetes mellitus	0.000762	0.00838	CbGeAlD
Pazopanib—FLT1—nephron tubule—type 1 diabetes mellitus	0.000761	0.00837	CbGeAlD
Pazopanib—FLT4—lymphoid tissue—type 1 diabetes mellitus	0.000739	0.00812	CbGeAlD
Pazopanib—FGFR2—cardiovascular system—type 1 diabetes mellitus	0.000737	0.00811	CbGeAlD
Pazopanib—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.000728	0.0135	CcSEcCtD
Pazopanib—FGFR2—kidney—type 1 diabetes mellitus	0.000722	0.00793	CbGeAlD
Pazopanib—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.000718	0.0133	CcSEcCtD
Pazopanib—TAOK3—nephron tubule—type 1 diabetes mellitus	0.000718	0.00789	CbGeAlD
Pazopanib—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00071	0.0131	CcSEcCtD
Pazopanib—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000703	0.013	CcSEcCtD
Pazopanib—MAP3K2—lymphoid tissue—type 1 diabetes mellitus	0.000697	0.00766	CbGeAlD
Pazopanib—PDGFRB—islet of Langerhans—type 1 diabetes mellitus	0.000692	0.0076	CbGeAlD
Pazopanib—FLT1—cardiovascular system—type 1 diabetes mellitus	0.000684	0.00752	CbGeAlD
Pazopanib—KDR—retina—type 1 diabetes mellitus	0.000683	0.00751	CbGeAlD
Pazopanib—FLT1—kidney—type 1 diabetes mellitus	0.000669	0.00735	CbGeAlD
Pazopanib—FLT1—pancreas—type 1 diabetes mellitus	0.000664	0.00731	CbGeAlD
Pazopanib—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.000659	0.0122	CcSEcCtD
Pazopanib—FGF1—lymphoid tissue—type 1 diabetes mellitus	0.000656	0.00722	CbGeAlD
Pazopanib—STK10—cardiovascular system—type 1 diabetes mellitus	0.000647	0.00712	CbGeAlD
Pazopanib—TAOK3—cardiovascular system—type 1 diabetes mellitus	0.000645	0.00709	CbGeAlD
Pazopanib—KDR—nephron tubule—type 1 diabetes mellitus	0.000643	0.00707	CbGeAlD
Pazopanib—PDGFRA—cardiovascular system—type 1 diabetes mellitus	0.000641	0.00704	CbGeAlD
Pazopanib—STK10—kidney—type 1 diabetes mellitus	0.000633	0.00696	CbGeAlD
Pazopanib—TAOK3—kidney—type 1 diabetes mellitus	0.000631	0.00694	CbGeAlD
Pazopanib—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000628	0.0116	CcSEcCtD
Pazopanib—TAOK3—pancreas—type 1 diabetes mellitus	0.000627	0.00689	CbGeAlD
Pazopanib—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000613	0.0113	CcSEcCtD
Pazopanib—UGT1A1—kidney—type 1 diabetes mellitus	0.000598	0.00657	CbGeAlD
Pazopanib—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000591	0.0109	CcSEcCtD
Pazopanib—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000587	0.0109	CcSEcCtD
Pazopanib—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000584	0.0108	CcSEcCtD
Pazopanib—Jaundice—Ramipril—type 1 diabetes mellitus	0.000584	0.0108	CcSEcCtD
Pazopanib—KDR—cardiovascular system—type 1 diabetes mellitus	0.000578	0.00635	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—type 1 diabetes mellitus	0.000578	0.00635	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—type 1 diabetes mellitus	0.000574	0.00632	CbGeAlD
Pazopanib—KIT—nephron tubule—type 1 diabetes mellitus	0.00057	0.00627	CbGeAlD
Pazopanib—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000567	0.0105	CcSEcCtD
Pazopanib—KDR—kidney—type 1 diabetes mellitus	0.000565	0.00622	CbGeAlD
Pazopanib—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000565	0.0104	CcSEcCtD
Pazopanib—CSF1R—cardiovascular system—type 1 diabetes mellitus	0.000564	0.0062	CbGeAlD
Pazopanib—STK10—lymphoid tissue—type 1 diabetes mellitus	0.000544	0.00598	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—type 1 diabetes mellitus	0.000542	0.00596	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—type 1 diabetes mellitus	0.000538	0.00592	CbGeAlD
Pazopanib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00053	0.0098	CcSEcCtD
Pazopanib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000529	0.00977	CcSEcCtD
Pazopanib—KIT—cardiovascular system—type 1 diabetes mellitus	0.000512	0.00563	CbGeAlD
Pazopanib—KIT—kidney—type 1 diabetes mellitus	0.000501	0.00551	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—type 1 diabetes mellitus	0.0005	0.0055	CbGeAlD
Pazopanib—Flushing—Ramipril—type 1 diabetes mellitus	0.000499	0.00923	CcSEcCtD
Pazopanib—KIT—pancreas—type 1 diabetes mellitus	0.000498	0.00547	CbGeAlD
Pazopanib—SLCO1B1—kidney—type 1 diabetes mellitus	0.000497	0.00547	CbGeAlD
Pazopanib—PDGFRB—kidney—type 1 diabetes mellitus	0.000489	0.00538	CbGeAlD
Pazopanib—PDGFRB—pancreas—type 1 diabetes mellitus	0.000486	0.00535	CbGeAlD
Pazopanib—KDR—lymphoid tissue—type 1 diabetes mellitus	0.000486	0.00534	CbGeAlD
Pazopanib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000485	0.00896	CcSEcCtD
Pazopanib—Alopecia—Ramipril—type 1 diabetes mellitus	0.000475	0.00879	CcSEcCtD
Pazopanib—CSF1R—lymphoid tissue—type 1 diabetes mellitus	0.000474	0.00521	CbGeAlD
Pazopanib—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000471	0.00871	CcSEcCtD
Pazopanib—Erythema—Ramipril—type 1 diabetes mellitus	0.000468	0.00866	CcSEcCtD
Pazopanib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000468	0.00866	CcSEcCtD
Pazopanib—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000459	0.00848	CcSEcCtD
Pazopanib—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00045	0.00832	CcSEcCtD
Pazopanib—KIT—lymphoid tissue—type 1 diabetes mellitus	0.00043	0.00473	CbGeAlD
Pazopanib—PDGFRB—lymphoid tissue—type 1 diabetes mellitus	0.00042	0.00462	CbGeAlD
Pazopanib—Syncope—Ramipril—type 1 diabetes mellitus	0.00042	0.00776	CcSEcCtD
Pazopanib—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000419	0.00775	CcSEcCtD
Pazopanib—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000412	0.00761	CcSEcCtD
Pazopanib—Cough—Ramipril—type 1 diabetes mellitus	0.000409	0.00755	CcSEcCtD
Pazopanib—Myalgia—Ramipril—type 1 diabetes mellitus	0.000399	0.00737	CcSEcCtD
Pazopanib—Chest pain—Ramipril—type 1 diabetes mellitus	0.000399	0.00737	CcSEcCtD
Pazopanib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000399	0.00737	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000396	0.00732	CcSEcCtD
Pazopanib—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00039	0.00721	CcSEcCtD
Pazopanib—Oedema—Ramipril—type 1 diabetes mellitus	0.000382	0.00707	CcSEcCtD
Pazopanib—Shock—Ramipril—type 1 diabetes mellitus	0.000376	0.00695	CcSEcCtD
Pazopanib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000375	0.00693	CcSEcCtD
Pazopanib—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000374	0.00692	CcSEcCtD
Pazopanib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000371	0.00686	CcSEcCtD
Pazopanib—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000369	0.00683	CcSEcCtD
Pazopanib—Anorexia—Ramipril—type 1 diabetes mellitus	0.000364	0.00673	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000348	0.00644	CcSEcCtD
Pazopanib—Insomnia—Ramipril—type 1 diabetes mellitus	0.000346	0.00639	CcSEcCtD
Pazopanib—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000343	0.00634	CcSEcCtD
Pazopanib—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000341	0.0063	CcSEcCtD
Pazopanib—Somnolence—Ramipril—type 1 diabetes mellitus	0.00034	0.00628	CcSEcCtD
Pazopanib—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000336	0.00622	CcSEcCtD
Pazopanib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000332	0.00614	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00033	0.0061	CcSEcCtD
Pazopanib—Fatigue—Ramipril—type 1 diabetes mellitus	0.00033	0.00609	CcSEcCtD
Pazopanib—ABCG2—nephron tubule—type 1 diabetes mellitus	0.000313	0.00344	CbGeAlD
Pazopanib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000313	0.00578	CcSEcCtD
Pazopanib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000302	0.00559	CcSEcCtD
Pazopanib—CYP2C8—kidney—type 1 diabetes mellitus	0.000283	0.00311	CbGeAlD
Pazopanib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000274	0.00507	CcSEcCtD
Pazopanib—Pruritus—Ramipril—type 1 diabetes mellitus	0.00027	0.005	CcSEcCtD
Pazopanib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000261	0.00483	CcSEcCtD
Pazopanib—Dizziness—Ramipril—type 1 diabetes mellitus	0.000253	0.00467	CcSEcCtD
Pazopanib—Vomiting—Ramipril—type 1 diabetes mellitus	0.000243	0.00449	CcSEcCtD
Pazopanib—Rash—Ramipril—type 1 diabetes mellitus	0.000241	0.00445	CcSEcCtD
Pazopanib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000241	0.00445	CcSEcCtD
Pazopanib—Headache—Ramipril—type 1 diabetes mellitus	0.000239	0.00443	CcSEcCtD
Pazopanib—Nausea—Ramipril—type 1 diabetes mellitus	0.000227	0.0042	CcSEcCtD
Pazopanib—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000192	0.00211	CbGeAlD
Pazopanib—CYP3A4—kidney—type 1 diabetes mellitus	0.000192	0.00211	CbGeAlD
Pazopanib—CYP2D6—kidney—type 1 diabetes mellitus	0.000189	0.00207	CbGeAlD
Pazopanib—ABCB1—retina—type 1 diabetes mellitus	0.000164	0.0018	CbGeAlD
Pazopanib—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000154	0.0017	CbGeAlD
Pazopanib—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000139	0.00152	CbGeAlD
Pazopanib—ABCB1—kidney—type 1 diabetes mellitus	0.000136	0.00149	CbGeAlD
Pazopanib—ABCB1—pancreas—type 1 diabetes mellitus	0.000135	0.00148	CbGeAlD
Pazopanib—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000116	0.00128	CbGeAlD
Pazopanib—KDR—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.82e-06	2.72e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	4.8e-06	2.71e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD80—type 1 diabetes mellitus	4.77e-06	2.69e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	4.77e-06	2.69e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.75e-06	2.68e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	4.73e-06	2.67e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—type 1 diabetes mellitus	4.7e-06	2.65e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.7e-06	2.65e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.7e-06	2.65e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—IL6—type 1 diabetes mellitus	4.69e-06	2.65e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.69e-06	2.64e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.68e-06	2.64e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—STAT3—type 1 diabetes mellitus	4.68e-06	2.64e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	4.68e-06	2.64e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—IL6—type 1 diabetes mellitus	4.68e-06	2.64e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.67e-06	2.64e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—IL6—type 1 diabetes mellitus	4.67e-06	2.64e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—type 1 diabetes mellitus	4.67e-06	2.63e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—type 1 diabetes mellitus	4.67e-06	2.63e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—type 1 diabetes mellitus	4.65e-06	2.63e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.65e-06	2.62e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—type 1 diabetes mellitus	4.65e-06	2.62e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—type 1 diabetes mellitus	4.65e-06	2.62e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—type 1 diabetes mellitus	4.64e-06	2.62e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TYK2—type 1 diabetes mellitus	4.64e-06	2.61e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—EGFR—type 1 diabetes mellitus	4.61e-06	2.6e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.61e-06	2.6e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—type 1 diabetes mellitus	4.6e-06	2.6e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.6e-06	2.59e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CD80—type 1 diabetes mellitus	4.59e-06	2.59e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.58e-06	2.58e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NOS3—type 1 diabetes mellitus	4.55e-06	2.57e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS2—type 1 diabetes mellitus	4.54e-06	2.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—type 1 diabetes mellitus	4.54e-06	2.56e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.51e-06	2.54e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CD80—type 1 diabetes mellitus	4.51e-06	2.54e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—type 1 diabetes mellitus	4.45e-06	2.51e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	4.44e-06	2.5e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD80—type 1 diabetes mellitus	4.41e-06	2.49e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—EGFR—type 1 diabetes mellitus	4.4e-06	2.48e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.39e-06	2.48e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—INS—type 1 diabetes mellitus	4.34e-06	2.45e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	4.32e-06	2.43e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.28e-06	2.41e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CD80—type 1 diabetes mellitus	4.27e-06	2.41e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL6—type 1 diabetes mellitus	4.26e-06	2.4e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—INS—type 1 diabetes mellitus	4.26e-06	2.4e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—EGFR—type 1 diabetes mellitus	4.26e-06	2.4e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CD86—type 1 diabetes mellitus	4.23e-06	2.39e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—EGFR—type 1 diabetes mellitus	4.23e-06	2.38e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—type 1 diabetes mellitus	4.22e-06	2.38e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	4.2e-06	2.37e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.2e-06	2.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—STAT3—type 1 diabetes mellitus	4.2e-06	2.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.2e-06	2.37e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—type 1 diabetes mellitus	4.19e-06	2.36e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—type 1 diabetes mellitus	4.19e-06	2.36e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—type 1 diabetes mellitus	4.19e-06	2.36e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	4.18e-06	2.36e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	4.18e-06	2.36e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—type 1 diabetes mellitus	4.18e-06	2.36e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—INS—type 1 diabetes mellitus	4.16e-06	2.35e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	4.15e-06	2.34e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—type 1 diabetes mellitus	4.13e-06	2.33e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—STAT3—type 1 diabetes mellitus	4.12e-06	2.32e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.12e-06	2.32e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—type 1 diabetes mellitus	4.11e-06	2.32e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	4.1e-06	2.31e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.09e-06	2.31e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—type 1 diabetes mellitus	4.09e-06	2.31e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—type 1 diabetes mellitus	4.08e-06	2.3e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	4.08e-06	2.3e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—INS—type 1 diabetes mellitus	4.04e-06	2.28e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—INS—type 1 diabetes mellitus	4.03e-06	2.27e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—TYK2—type 1 diabetes mellitus	4.03e-06	2.27e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.01e-06	2.26e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—INS—type 1 diabetes mellitus	3.98e-06	2.25e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.95e-06	2.23e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	3.94e-06	2.22e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—type 1 diabetes mellitus	3.94e-06	2.22e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	3.91e-06	2.21e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—STAT3—type 1 diabetes mellitus	3.91e-06	2.21e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.91e-06	2.21e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.9e-06	2.2e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—STAT3—type 1 diabetes mellitus	3.9e-06	2.2e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.9e-06	2.2e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.9e-06	2.2e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.88e-06	2.19e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—STAT3—type 1 diabetes mellitus	3.88e-06	2.19e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CD80—type 1 diabetes mellitus	3.85e-06	2.17e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	3.84e-06	2.17e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—EGFR—type 1 diabetes mellitus	3.81e-06	2.15e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.81e-06	2.15e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.81e-06	2.15e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—STAT3—type 1 diabetes mellitus	3.81e-06	2.15e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.8e-06	2.15e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—type 1 diabetes mellitus	3.77e-06	2.13e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CD80—type 1 diabetes mellitus	3.76e-06	2.12e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.75e-06	2.12e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—EGFR—type 1 diabetes mellitus	3.75e-06	2.11e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.74e-06	2.11e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	3.73e-06	2.1e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TYK2—type 1 diabetes mellitus	3.72e-06	2.1e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.7e-06	2.09e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS3—type 1 diabetes mellitus	3.65e-06	2.06e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—type 1 diabetes mellitus	3.65e-06	2.06e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—INS—type 1 diabetes mellitus	3.65e-06	2.06e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—type 1 diabetes mellitus	3.64e-06	2.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—INS—type 1 diabetes mellitus	3.63e-06	2.05e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.61e-06	2.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—STAT3—type 1 diabetes mellitus	3.61e-06	2.04e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.61e-06	2.04e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.6e-06	2.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—STAT3—type 1 diabetes mellitus	3.6e-06	2.03e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.59e-06	2.02e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.58e-06	2.02e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—INS—type 1 diabetes mellitus	3.56e-06	2.01e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EGFR—type 1 diabetes mellitus	3.56e-06	2.01e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EGFR—type 1 diabetes mellitus	3.55e-06	2e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.55e-06	2e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	3.55e-06	2e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—type 1 diabetes mellitus	3.54e-06	2e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.54e-06	1.99e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.53e-06	1.99e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EGFR—type 1 diabetes mellitus	3.52e-06	1.99e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—STAT3—type 1 diabetes mellitus	3.52e-06	1.98e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.51e-06	1.98e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NOS3—type 1 diabetes mellitus	3.49e-06	1.97e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—EGFR—type 1 diabetes mellitus	3.46e-06	1.95e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—STAT3—type 1 diabetes mellitus	3.44e-06	1.94e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.44e-06	1.94e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.44e-06	1.94e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—type 1 diabetes mellitus	3.38e-06	1.91e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—INS—type 1 diabetes mellitus	3.38e-06	1.91e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—type 1 diabetes mellitus	3.37e-06	1.9e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—type 1 diabetes mellitus	3.36e-06	1.9e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—type 1 diabetes mellitus	3.35e-06	1.89e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—type 1 diabetes mellitus	3.34e-06	1.89e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	3.34e-06	1.88e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	3.32e-06	1.87e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EGFR—type 1 diabetes mellitus	3.28e-06	1.85e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.28e-06	1.85e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EGFR—type 1 diabetes mellitus	3.27e-06	1.85e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—type 1 diabetes mellitus	3.27e-06	1.84e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	3.26e-06	1.84e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	3.25e-06	1.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.25e-06	1.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—STAT3—type 1 diabetes mellitus	3.25e-06	1.83e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	3.24e-06	1.83e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.23e-06	1.82e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.23e-06	1.82e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.21e-06	1.81e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NOS3—type 1 diabetes mellitus	3.2e-06	1.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EGFR—type 1 diabetes mellitus	3.2e-06	1.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.19e-06	1.8e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.18e-06	1.79e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.17e-06	1.79e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—type 1 diabetes mellitus	3.17e-06	1.79e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	3.16e-06	1.78e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—EGFR—type 1 diabetes mellitus	3.13e-06	1.76e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.12e-06	1.76e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.12e-06	1.76e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	3.1e-06	1.75e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CD80—type 1 diabetes mellitus	3.09e-06	1.74e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	3.06e-06	1.73e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.01e-06	1.7e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.01e-06	1.7e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CASP3—type 1 diabetes mellitus	3e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3e-06	1.69e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—type 1 diabetes mellitus	3e-06	1.69e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.98e-06	1.68e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	2.96e-06	1.67e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EGFR—type 1 diabetes mellitus	2.95e-06	1.66e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—type 1 diabetes mellitus	2.93e-06	1.65e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—INS—type 1 diabetes mellitus	2.92e-06	1.64e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—type 1 diabetes mellitus	2.88e-06	1.62e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—STAT3—type 1 diabetes mellitus	2.82e-06	1.59e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.82e-06	1.59e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.76e-06	1.55e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	2.75e-06	1.55e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	2.74e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—type 1 diabetes mellitus	2.73e-06	1.54e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—type 1 diabetes mellitus	2.73e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.71e-06	1.53e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—type 1 diabetes mellitus	2.71e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.71e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—type 1 diabetes mellitus	2.7e-06	1.52e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.67e-06	1.5e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—type 1 diabetes mellitus	2.66e-06	1.5e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.65e-06	1.49e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—type 1 diabetes mellitus	2.64e-06	1.49e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.61e-06	1.47e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—type 1 diabetes mellitus	2.6e-06	1.47e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	2.59e-06	1.46e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	2.59e-06	1.46e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	2.58e-06	1.45e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—EGFR—type 1 diabetes mellitus	2.56e-06	1.45e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	2.56e-06	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.56e-06	1.44e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.53e-06	1.43e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—type 1 diabetes mellitus	2.52e-06	1.42e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.52e-06	1.42e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—type 1 diabetes mellitus	2.52e-06	1.42e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	2.51e-06	1.42e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.47e-06	1.39e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—type 1 diabetes mellitus	2.46e-06	1.39e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—type 1 diabetes mellitus	2.46e-06	1.38e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.42e-06	1.37e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—type 1 diabetes mellitus	2.4e-06	1.36e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—type 1 diabetes mellitus	2.4e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—EGFR—type 1 diabetes mellitus	2.37e-06	1.34e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.3e-06	1.3e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.29e-06	1.29e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.29e-06	1.29e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.27e-06	1.28e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—type 1 diabetes mellitus	2.27e-06	1.28e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.23e-06	1.25e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	2.2e-06	1.24e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.17e-06	1.22e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—type 1 diabetes mellitus	2.17e-06	1.22e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	2.1e-06	1.18e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.07e-06	1.17e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.02e-06	1.14e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	2e-06	1.13e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—type 1 diabetes mellitus	1.97e-06	1.11e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	1.92e-06	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.9e-06	1.07e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—type 1 diabetes mellitus	1.86e-06	1.05e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	1.84e-06	1.04e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—INS—type 1 diabetes mellitus	1.83e-06	1.03e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.82e-06	1.03e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—type 1 diabetes mellitus	1.82e-06	1.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.77e-06	9.96e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—type 1 diabetes mellitus	1.76e-06	9.94e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	1.72e-06	9.71e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	1.7e-06	9.56e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	1.67e-06	9.44e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.66e-06	9.35e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	1.6e-06	9.03e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—type 1 diabetes mellitus	1.59e-06	8.95e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	1.58e-06	8.9e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—type 1 diabetes mellitus	1.55e-06	8.77e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	1.51e-06	8.51e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	1.46e-06	8.22e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	1.34e-06	7.54e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	1.28e-06	7.21e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—type 1 diabetes mellitus	1.27e-06	7.19e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.13e-06	6.35e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.03e-06	5.82e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	9.87e-07	5.56e-06	CbGpPWpGaD
